Literature DB >> 3395511

Adenine nucleotide metabolism by isolated kidney tubules during oxygen deprivation.

J M Weinberg1.   

Abstract

Suspensions enriched in isolated rabbit proximal tubules were subjected to varying degrees of oxygen deprivation-induced injury by incubating them under hypoxic conditions at pH 7.4 or pH 6.6 or under high density pelleted conditions and adenine nucleotide degradation was characterized. The major metabolite was hypoxanthine. Its levels increased with the extent of irreversible injury. It was not further degraded or salvaged. Recovery of cell ATP during reoxygenation was predominantly from the remaining cell nucleotides. Allopurinol did not alter the pattern of purine metabolism or the extent of cell injury. These observations provide information on the intrinsic purine metabolic capacity of renal tubule cells during oxygen deprivation which is relevant to understanding both the salvage mechanisms available in these cells as well as the contribution of purine metabolism to the pathogenesis of oxygen deprivation-induced tubule cell injury.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3395511     DOI: 10.1016/0885-4505(88)90092-8

Source DB:  PubMed          Journal:  Biochem Med Metab Biol        ISSN: 0885-4505


  3 in total

1.  Preserving postischemic reperfusion in the kidney: a role for extracellular adenosine.

Authors:  Joel M Weinberg; Manjeri A Venkatachalam
Journal:  J Clin Invest       Date:  2012-01-24       Impact factor: 14.808

2.  Anaerobic and aerobic pathways for salvage of proximal tubules from hypoxia-induced mitochondrial injury.

Authors:  J M Weinberg; M A Venkatachalam; N F Roeser; P Saikumar; Z Dong; R A Senter; I Nissim
Journal:  Am J Physiol Renal Physiol       Date:  2000-11

3.  Energetic determinants of tyrosine phosphorylation of focal adhesion proteins during hypoxia/reoxygenation of kidney proximal tubules.

Authors:  J M Weinberg; M A Venkatachalam; N F Roeser; R A Senter; I Nissim
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.